ONCOLOGY

The purpose of this Phase 1, multicenter, open-label study is to determine the maximum tolerated dose (MTD) of AG-636 and characterize its dose-limiting toxicities (DLTs) when given by mouth to…

According to a systematic review and meta-analysis, patients who have severe aortic stenosis and active cancer appear to benefit from transcatheter aortic-valve replacement with mortality rates…

According to findings published online from the Global Burden of Disease, increase in Liver Cancer rates has occurred primarily in men older than 60 years in developed countries. In contrast, the…

Therapeutic cancer vaccines were initially developed a century ago and have remained broadly ineffective to date. Li Tang’s team at EPFL’s School of Engineering has come up with…

This is a randomized pilot trial to estimate the effect of rosuvastatin on levels of tissue factor bearing microparticles (TFMP) in patients undergoing surgery for presumed ovarian cancer (…

The ASCO-SITC Clinical Immuno-Oncology Symposium focuses on clinical and translational advances in immuno-oncology. Expert faculty will offer new insights on the application of immunotherapy in…

This book addresses surgical management for recurrent soft tissue sarcomas (RSTS) based on a wealth of clinical cases. The first part introduces the general theory of surgical treatment for RSTS.…

Dr. Mesa discusses the approval of fedratinib (Inrebic) in myelofibrosis and other JAK inhibitors in the treatment pipeline. Fedratinib, which was approved in August 2019 for use in adult patients…